Tego BioSciences is developing and commercializing therapeutics based on modified fullerenes. The patent protected platform forms the basis for several different products. The company is initially focused on commercializing anti-wrinkle skin creams and cosmetics. Tego is also developing products to reduce the side effects of radiation therapy and chemotherapy and mitigate complications associated with organ transplantation and tissue engineering. For other applications of the technology such as MRI imaging or central nervous system disorders, Tego will partner with and license its intellectual property to third parties.

Tego BioSciences is a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR).